Timothy J. O’Brien, University of Arkansas for Medical Sciences, Little Rock, USA, “The Potential Of Kallikreins as Early Stage Tumor Markers for Cancers of the Reproductive Tract.”

Julie Chao, Medical University of South California, Charleston, USA, “Kallikrein/Kinin System.”

Judith Clements, School of Life Sciences & Science Research Centre, Queensland University of Technology, Brisbane, Australia, “Kallikreins and Their Variant Forms in Cancer Cell Biology.”

David Deperthes, CHUV, Université de Lausanne, Switzerland, “hK2 as Therapeutic Target for Prostate Cancer.”

Morley D. Hollenberg, Department of Pharmacology and Therapeutics, University of Calgary, Canada, “Proteinase Activated Receptors and Kallikreins.”

Ake Lundwall, Lund University, Malmo, Sweden, “Phylogenetics of Kallikrein Families.”

Viktor Magdolen, Klinishce Forschergruppe der Frauenklinik, Münich, “Biochemical and Structural Analysis of Human Tissue Kallikrein 4 (hK4)”

Georgia Sotiropoulou, School of Health Sciences, University of Patras, Greece, “Regulation of Human Kallikrein 6.”

Ulf-Hakan Stenman, Helsinki University Central Hospital, Finland, “What’s New with PS.”

Thomas K. Takayama, Departments of Biochemistry and Urology, University of Washington, USA, “Human Kallikrein 15: Last but not Least”

Georges M. Yousef, St. Johns University, Canada, “Tissue Expression of Human Kallikreins.”